1 – 4 of 4
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Compound genetically engineered mouse models of cancer reveal dual targeting of ALK1 and endoglin as a synergistic opportunity to impinge on angiogenic TGF-β signaling
(
- Contribution to journal › Article
- 2015
-
Mark
Endothelial ALK1 Is a Therapeutic Target to Block Metastatic Dissemination of Breast Cancer.
(
- Contribution to journal › Article
- 2013
-
Mark
Deficiency for endoglin in tumor vasculature weakens the endothelial barrier to metastatic dissemination
(
- Contribution to journal › Article
-
Mark
Bone morphogenetic protein-9 inhibits lymphatic vessel formation via activin receptor-like kinase 1 during development and cancer progression
(
- Contribution to journal › Article